Although HbA1c showed an increase both in the group switched to pitavastatin and the BMI < 25 group ( P-values : 0.035 and 0.033 ) and HOMA - showed a decrease in the BMI < 25 group ( P-values : 0.044 ) , there were no significant differences in changes between each divided group and their counterparts .